Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 481 to 488 of 488 entries
Sorted by: Best Match Show Resources per page
Usefulness of histological superstudy of sentinel lymph nodes detected with radioisotopes in colon cancer.

Revista espanola de medicina nuclear e imagen molecular

Serrano Del Moral Á, Pérez Viejo E, Castaño Pascual Á, Llorente Herrero E, Rodríguez Caravaca G, Duran Poveda M, Pereira Pérez F.
PMID: 34752369
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 Nov-Dec;40(6):358-366. doi: 10.1016/j.remnie.2021.03.019. Epub 2021 Mar 30.

INTRODUCTION: Adjuvant chemotherapy (CT) significally reduces the rate of relapse in +pN (stage III) colon cancer (CC) and in some pN0 (stage II) with risk factors such as pT4, vascular invasion V1, perineural invasion Pn1, and complicated tumors. However,...

Cite
Serrano Del Moral Á, Pérez Viejo E, Castaño Pascual Á, et al. Usefulness of histological superstudy of sentinel lymph nodes detected with radioisotopes in colon cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021;40(6):358-366doi: 10.1016/j.remnie.2021.03.019.
Serrano Del Moral, �. �., Pérez Viejo, E., Castaño Pascual, �. �., Llorente Herrero, E., Rodríguez Caravaca, G., Duran Poveda, M., & Pereira Pérez, F. (2021). Usefulness of histological superstudy of sentinel lymph nodes detected with radioisotopes in colon cancer. Revista espanola de medicina nuclear e imagen molecular, 40(6), 358-366. https://doi.org/10.1016/j.remnie.2021.03.019
Serrano Del Moral, Á, et al. "Usefulness of histological superstudy of sentinel lymph nodes detected with radioisotopes in colon cancer." Revista espanola de medicina nuclear e imagen molecular vol. 40,6 (2021): 358-366. doi: https://doi.org/10.1016/j.remnie.2021.03.019
Serrano Del Moral Á, Pérez Viejo E, Castaño Pascual Á, Llorente Herrero E, Rodríguez Caravaca G, Duran Poveda M, Pereira Pérez F. Usefulness of histological superstudy of sentinel lymph nodes detected with radioisotopes in colon cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 Nov-Dec;40(6):358-366. doi: 10.1016/j.remnie.2021.03.019. Epub 2021 Mar 30. PMID: 34752369.
Copy Download .nbib Format: NLM
Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms.

Molecular diagnosis & therapy

Brilhante-da-Silva N, de Oliveira Sousa RM, Arruda A, Dos Santos EL, Marinho ACM, Stabeli RG, Fernandes CFC, Pereira SDS.
PMID: 34146333
Mol Diagn Ther. 2021 Jul;25(4):439-456. doi: 10.1007/s40291-021-00533-7. Epub 2021 Jun 19.

The distinct biophysical and pharmaceutical properties of camelid single-domain antibodies, referred to as VHHs or nanobodies, are associated with their nanometric dimensions, elevated stability, and antigen recognition capacity. These biomolecules can circumvent a number of diagnostic system limitations, especially...

Cite
Brilhante-da-Silva N, de Oliveira Sousa RM, Arruda A, et al. Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms. Mol Diagn Ther. 2021;25(4):439-456doi: 10.1007/s40291-021-00533-7.
Brilhante-da-Silva, N., de Oliveira Sousa, R. M., Arruda, A., Dos Santos, E. L., Marinho, A. C. M., Stabeli, R. G., Fernandes, C. F. C., & Pereira, S. D. S. (2021). Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms. Molecular diagnosis & therapy, 25(4), 439-456. https://doi.org/10.1007/s40291-021-00533-7
Brilhante-da-Silva, Nairo, et al. "Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms." Molecular diagnosis & therapy vol. 25,4 (2021): 439-456. doi: https://doi.org/10.1007/s40291-021-00533-7
Brilhante-da-Silva N, de Oliveira Sousa RM, Arruda A, Dos Santos EL, Marinho ACM, Stabeli RG, Fernandes CFC, Pereira SDS. Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms. Mol Diagn Ther. 2021 Jul;25(4):439-456. doi: 10.1007/s40291-021-00533-7. Epub 2021 Jun 19. PMID: 34146333.
Copy Download .nbib Format: NLM
Novel Bifunctional [16]aneS.

Molecules (Basel, Switzerland)

Straathof NJW, Magnus CB, Zhuravlev F, Jensen AI.
PMID: 34361752
Molecules. 2021 Jul 29;26(15). doi: 10.3390/molecules26154603.

The field of targeted radionuclide therapy is rapidly growing, highlighting the need for wider radionuclide availability. Soft Lewis acid ions, such as radioisotopes of platinum, rhodium and palladium, are particularly underdeveloped. This is due in part to a lack...

Cite
Straathof NJW, Magnus CB, Zhuravlev F, et al. Novel Bifunctional [16]aneS. Molecules. 2021;26(15)doi: 10.3390/molecules26154603.
Straathof, N. J. W., Magnus, C. B., Zhuravlev, F., & Jensen, A. I. (2021). Novel Bifunctional [16]aneS. Molecules (Basel, Switzerland), 26(15), . https://doi.org/10.3390/molecules26154603
Straathof, Natan J W, et al. "Novel Bifunctional [16]aneS." Molecules (Basel, Switzerland) vol. 26,15 (2021). doi: https://doi.org/10.3390/molecules26154603
Straathof NJW, Magnus CB, Zhuravlev F, Jensen AI. Novel Bifunctional [16]aneS. Molecules. 2021 Jul 29;26(15). doi: 10.3390/molecules26154603. PMID: 34361752; PMCID: PMC8348053.
Copy Download .nbib Format: NLM
Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer.

Journal of drug targeting

Ciobanasu C.
PMID: 33775187
J Drug Target. 2021 Dec;29(10):1063-1079. doi: 10.1080/1061186X.2021.1906885. Epub 2021 Apr 01.

In recent years, remarkable progress was registered in the field of cancer research. Though, cancer still represents a major cause of death and cancer metastasis a problem seeking for urgent solutions as it is the main reason for therapeutic...

Cite
Ciobanasu C. Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer. J Drug Target. 2021;29(10):1063-1079doi: 10.1080/1061186X.2021.1906885.
Ciobanasu, C. (2021). Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer. Journal of drug targeting, 29(10), 1063-1079. https://doi.org/10.1080/1061186X.2021.1906885
Ciobanasu, Corina. "Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer." Journal of drug targeting vol. 29,10 (2021): 1063-1079. doi: https://doi.org/10.1080/1061186X.2021.1906885
Ciobanasu C. Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer. J Drug Target. 2021 Dec;29(10):1063-1079. doi: 10.1080/1061186X.2021.1906885. Epub 2021 Apr 01. PMID: 33775187.
Copy Download .nbib Format: NLM
Production of a broad palette of positron emitting radioisotopes using a low-energy cyclotron: Towards a new success story in cancer imaging?.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine

Chakravarty R, Chakraborty S.
PMID: 34284216
Appl Radiat Isot. 2021 Oct;176:109860. doi: 10.1016/j.apradiso.2021.109860. Epub 2021 Jul 12.

Over the last several years, positron emission tomography (PET) has matured as an indispensable component of cancer diagnostics. Owing to the large variability observed among the cancer patients and the need to personalize individual patient's diagnosis and treatment, the...

Cite
Chakravarty R, Chakraborty S. Production of a broad palette of positron emitting radioisotopes using a low-energy cyclotron: Towards a new success story in cancer imaging?. Appl Radiat Isot. 2021;176:109860doi: 10.1016/j.apradiso.2021.109860.
Chakravarty, R., & Chakraborty, S. (2021). Production of a broad palette of positron emitting radioisotopes using a low-energy cyclotron: Towards a new success story in cancer imaging?. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 176109860. https://doi.org/10.1016/j.apradiso.2021.109860
Chakravarty, Rubel, and Chakraborty, Sudipta. "Production of a broad palette of positron emitting radioisotopes using a low-energy cyclotron: Towards a new success story in cancer imaging?." Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine vol. 176 (2021): 109860. doi: https://doi.org/10.1016/j.apradiso.2021.109860
Chakravarty R, Chakraborty S. Production of a broad palette of positron emitting radioisotopes using a low-energy cyclotron: Towards a new success story in cancer imaging?. Appl Radiat Isot. 2021 Oct;176:109860. doi: 10.1016/j.apradiso.2021.109860. Epub 2021 Jul 12. PMID: 34284216.
Copy Download .nbib Format: NLM
Control of Nanostructured Polysulfone Membrane Preparation by Phase Inversion Method.

Nanomaterials (Basel, Switzerland)

Urducea CB, Nechifor AC, Dimulescu IA, Oprea O, Nechifor G, Totu EE, Isildak I, Albu PC, Bungău SG.
PMID: 33256125
Nanomaterials (Basel). 2020 Nov 26;10(12). doi: 10.3390/nano10122349.

The preparation of membranes from polymer solutions by the phase inversion method, the immersion-precipitation technique has proved since the beginning of obtaining technological membranes the most versatile and simple possibility to create polymeric membrane nanostructures. Classically, the phase inversion...

Cite
Urducea CB, Nechifor AC, Dimulescu IA, et al. Control of Nanostructured Polysulfone Membrane Preparation by Phase Inversion Method. Nanomaterials (Basel). 2020;10(12)doi: 10.3390/nano10122349.
Urducea, C. B., Nechifor, A. C., Dimulescu, I. A., Oprea, O., Nechifor, G., Totu, E. E., Isildak, I., Albu, P. C., & Bungău, S. G. (2020). Control of Nanostructured Polysulfone Membrane Preparation by Phase Inversion Method. Nanomaterials (Basel, Switzerland), 10(12), . https://doi.org/10.3390/nano10122349
Urducea, Cristina Bărdacă, et al. "Control of Nanostructured Polysulfone Membrane Preparation by Phase Inversion Method." Nanomaterials (Basel, Switzerland) vol. 10,12 (2020). doi: https://doi.org/10.3390/nano10122349
Urducea CB, Nechifor AC, Dimulescu IA, Oprea O, Nechifor G, Totu EE, Isildak I, Albu PC, Bungău SG. Control of Nanostructured Polysulfone Membrane Preparation by Phase Inversion Method. Nanomaterials (Basel). 2020 Nov 26;10(12). doi: 10.3390/nano10122349. PMID: 33256125; PMCID: PMC7760602.
Copy Download .nbib Format: NLM
Recent Advances in Multimodal Molecular Imaging of Cancer Mediated by Hybrid Magnetic Nanoparticles.

Polymers

Luengo Morato Y, Ovejero Paredes K, Lozano Chamizo L, Marciello M, Filice M.
PMID: 34503029
Polymers (Basel). 2021 Sep 03;13(17). doi: 10.3390/polym13172989.

Cancer is the second leading cause of death in the world, which is why it is so important to make an early and very precise diagnosis to obtain a good prognosis. Thanks to the combination of several imaging modalities...

Cite
Luengo Morato Y, Ovejero Paredes K, Lozano Chamizo L, et al. Recent Advances in Multimodal Molecular Imaging of Cancer Mediated by Hybrid Magnetic Nanoparticles. Polymers (Basel). 2021;13(17)doi: 10.3390/polym13172989.
Luengo Morato, Y., Ovejero Paredes, K., Lozano Chamizo, L., Marciello, M., & Filice, M. (2021). Recent Advances in Multimodal Molecular Imaging of Cancer Mediated by Hybrid Magnetic Nanoparticles. Polymers, 13(17), . https://doi.org/10.3390/polym13172989
Luengo Morato, Yurena, et al. "Recent Advances in Multimodal Molecular Imaging of Cancer Mediated by Hybrid Magnetic Nanoparticles." Polymers vol. 13,17 (2021). doi: https://doi.org/10.3390/polym13172989
Luengo Morato Y, Ovejero Paredes K, Lozano Chamizo L, Marciello M, Filice M. Recent Advances in Multimodal Molecular Imaging of Cancer Mediated by Hybrid Magnetic Nanoparticles. Polymers (Basel). 2021 Sep 03;13(17). doi: 10.3390/polym13172989. PMID: 34503029; PMCID: PMC8434540.
Copy Download .nbib Format: NLM
Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes.

Theranostics

Benabdallah N, Scheve W, Dunn N, Silvestros D, Schelker P, Abou D, Jammalamadaka U, Laforest R, Li Z, Liu J, Ballard DH, Maughan NM, Gay H, Baumann BC, Hobbs RF, Rogers B, Iravani A, Jha AK, Dehdashti F, Thorek DLJ.
PMID: 34815780
Theranostics. 2021 Sep 27;11(20):9721-9737. doi: 10.7150/thno.63860. eCollection 2021.

No abstract available.

Cite
Benabdallah N, Scheve W, Dunn N, et al. Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes. Theranostics. 2021;11(20):9721-9737doi: 10.7150/thno.63860.
Benabdallah, N., Scheve, W., Dunn, N., Silvestros, D., Schelker, P., Abou, D., Jammalamadaka, U., Laforest, R., Li, Z., Liu, J., Ballard, D. H., Maughan, N. M., Gay, H., Baumann, B. C., Hobbs, R. F., Rogers, B., Iravani, A., Jha, A. K., Dehdashti, F., & Thorek, D. L. J. (2021). Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes. Theranostics, 11(20), 9721-9737. https://doi.org/10.7150/thno.63860
Benabdallah, Nadia, et al. "Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes." Theranostics vol. 11,20 (2021): 9721-9737. doi: https://doi.org/10.7150/thno.63860
Benabdallah N, Scheve W, Dunn N, Silvestros D, Schelker P, Abou D, Jammalamadaka U, Laforest R, Li Z, Liu J, Ballard DH, Maughan NM, Gay H, Baumann BC, Hobbs RF, Rogers B, Iravani A, Jha AK, Dehdashti F, Thorek DLJ. Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes. Theranostics. 2021 Sep 27;11(20):9721-9737. doi: 10.7150/thno.63860. eCollection 2021. PMID: 34815780; PMCID: PMC8581409.
Copy Download .nbib Format: NLM
Showing 481 to 488 of 488 entries